Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation

British Journal of Clinical Pharmacology

Volumn 53, Issue 5, 2002, Pages 474-484

  HeMagee, Mindy ^a   Blum, Robert A ^a   Lates, Christian D ^a   Jusko, William J ^b  

^a MILLARD FILLMORE HOSPITAL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cell trafficking; Gender; Indirect response models; Pharmacodynamics; Race

Indexed keywords

PREDNISOLONE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL TRANSPORT; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFECT; FEMALE; HUMAN; IC 50; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ADOLESCENT; BIOLOGICAL MODEL; BLOOD; CAUCASIAN; CELL DIVISION; CYTOLOGY; LYMPHOCYTE; MIDDLE AGED; NEGRO; SEX DIFFERENCE;

ADOLESCENT; ADULT; CAUCASOID RACE; CELL DIVISION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; LYMPHOCYTES; MIDDLE AGE; MODELS, BIOLOGICAL; NEGROID RACE; PREDNISOLONE; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MIDDLE AGED;

EID: 0036583479     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01567.x     Document Type: Article

References (21)

1. Molecular mechanisms of new immunosuppressants
2. Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in rats
3. Prednisolone dispostion in obese men
4. Corticosteroid analysis in biological fluids by high-performance liquid chromatography
5. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma
6. Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays
7. Circadian changes of T lymphocyte subsets in human peripheral blood
8. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking
9. The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo
10. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes
11. Immunopharmacologic therapy in renal transplantation
12. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
13. Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers
14. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man
15. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena
16. New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting
17. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor
18. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race
19. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits
20. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone